Isoergine

Pharmaceutical compound From Wikipedia, the free encyclopedia

Isoergine

Isoergine, also known as isolysergic acid amide (iso-LSA or iso-LA-819), isolysergamide, or erginine, is a serotonergic psychedelic of the ergoline and lysergamide families related to ergine (lysergic acid amide; LSA) and lysergic acid diethylamide (LSD).[2][3][4][5][1] It is the epimer of ergine inverted at the 8 position.[5][6][7][8] Along with ergine and other ergolines, isoergine occurs naturally in morning glories.[2][3][4][5][1][8] It is thought to be primarily responsible for the hallucinogenic effects of morning glory seeds.[3][1][2][4][6][9]

Quick Facts Clinical data, Other names ...
Isoergine
Thumb
Clinical data
Other namesIsolysergic acid amide; D-Isolysergic acid amide; Erginine; Isolysergamide; (+)-Isolysergic acid amide; Iso-LA; Iso-LA-819; Iso-LSA; d-Isolysergamide; 6-Methyl-9,10-didehydroergoline-8α-carboxamide
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H17N3O
Molar mass267.332 g·mol−1
3D model (JSmol)
  • CN1C[C@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N
  • InChI=1S/C16H17N3O/c1-19-8-10(16(17)20)5-12-11-3-2-4-13-15(11)9(7-18-13)6-14(12)19/h2-5,7,10,14,18H,6,8H2,1H3,(H2,17,20)/t10-,14+/m0/s1
  • Key:GENAHGKEFJLNJB-IINYFYTJSA-N
Close

Use and effects

Summarize
Perspective

Isoergine occurs naturally in morning glory species, including Ipomoea tricolor (tlitliltzin), Ipomoea corymbosa (ololiuhqui), and Argyreia nervosa (Hawaiian baby woodrose).[3][4][6] It has been found to constitute 8 to 35% of total alkaloid content relative to 5 to 58% for ergine.[4][6]

Albert Hofmann, the discoverer of LSD's psychedelic effects, tried 2 mg isoergine orally and experienced feelings of unreality, detachment from the outside world, feelings of mental emptiness, tiredness, and apathy, though no specific sensory distortions were mentioned.[4][5][1][8][10] He described its effects as similar to those of ergine, which he had tested at doses of up to 2 mg.[10] Subsequently Heim and colleagues assessed ergine at higher doses of 3 to 6 mg orally and observed toxic-like effects, while isoergine at 2 to 5 mg orally produced notable hallucinogenic effects.[2][3][1][9] The psychedelic effects of isoergine observed in this study included some euphoria, synaesthesia, and altered time perception.[3][1][9] However, although hallucinogenic, isoergine's effects were described as not LSD-like.[2]

It is thought that ergine and isoergine together may account for most or all of the effects of morning glory seeds, with ergine producing intoxication, sedation, and autonomic side effects and isoergine producing hallucinogenic effects.[3][1][2][4][6][9][11] Conversely, other notable constituents, including elymoclavine, lysergol, and chanoclavine, produced no psychoactive or hallucinogenic effects in humans.[1][2][12][13][14][15][8][9] Ergometrine, which is a minor constituent representing up to 8% of total alkaloids, is known to produce psychedelic effects only in higher amounts (2–10 mg) than those in typical doses of morning glory seeds and hence is thought to not contribute to the effects of the seeds either.[15][1][3][16][17][4] Moreover, ergometrine is present in Ipomoea tricolor and Argyreia nervosa but not in Ipomoea corymbosa.[1][3] Isoergine being responsible for the hallucinogenic effects of morning glory seeds is also supported by animal studies.[3][1][11] However, the poorly-stable lysergic acid hydroxyethylamides (LSHs) might still alternatively be involved in the psychedelic effects of morning glory seeds per Alexander Shulgin.[7]

Pharmacology

Summarize
Perspective

Pharmacodynamics

Isoergine shows affinity for serotonin receptors labeled with serotonin or LSD in rat brain membranes.[18][19][20] It has about 10- to 25-fold lower affinity for these receptors than serotonin or LSD and has the same affinity as ergine and iso-LSD (IC50Tooltip half-maximal inhibitory concentration = 100–200 nM for isoergine, 200 nM for ergine and iso-LSD, and 8–10 nM for LSD).[18][19][20] No other receptor interaction data are available for isoergine as of 2020.[3] However, computer-predicted receptor affinities are available for ergine/isoergine (stereochemistry not taken into account).[21] The drug is said to have about 4.3% of LSD's antiserotonergic potency in vitro.[22][23] It is 5- to 33-fold less potent than LSD in producing behavioral changes in the conditioned avoidance test in rodents.[3][4][24][11]

Pharmacokinetics

The pharmacokinetics of isoergine in rodents have been studied.[3][11] Isoergine is much less lipophilic than LSD, with log P values of 0.95 and 2.95, respectively.[20] This might influence its pharmacological properties, for instance reducing its blood–brain barrier permeability.[20] However, isoergine showed a similar ratio of brain-to-plasma levels as LSD in rodents.[11]

Chemistry

Derivatives

Derivatives of isoergine include isolysergic acid diethylamide (iso-LSD), isolysergic acid hydroxyethylamide (iso-LSH), and ergometrinine (isoergometrine; isolysergic acid propanolamide), among others.[2][25][4][26] With the apparent exception of isoergine, isolysergamides, such as iso-LSD, are said to be inactive as psychedelics in humans.[27][28][29][30][31] Iso-LSD is inactive as a psychedelic at a dose of up to 500 μg or up to 20 times the minimum active dose of LSD.[4][32][28] It has been found to possess about 30-fold lower serotonin receptor affinity than LSD in rat brain membranes.[28][18][19]

History

Isoergine was first identified by Sidney Smith and Geoffrey Timmis in 1936 via hydrolysis of ergot alkaloids.[1][33] This followed the identification of ergine in the same way in 1932.[1][34] Isoergine was first synthesized by Albert Hofmann and colleagues by 1949.[1][35] Subsequently, it was isolated by Hofmann and colleagues in morning glory seeds in 1960.[36][8][37] The psychoactive effects of isoergine were first described by Hofmann in 1963.[4][1][8] Heim and colleagues more clearly substantiated the hallucinogenic effects of isoergine and its role in producing the psychedelic effects of morning glory seeds in 1968.[3][1][9]

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.